Combined regimen of inhalable STING agonist plus chemoimmunotherapy in platinum-resistant or platinum-refratory ovarian cancer: A randomized, open-label, phase II trial.

被引：0

作者：

Zhang, Yan

Mei, Qian

Meng, Yuanguang

Chen, Meixia

Liu, Yang

Yang, Qingming

Han, Weidong

机构：

[1] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China

[2] Chinese Peoples Liberat Army Gen Hosp, Mol & Immunol Dept, Beijing, Peoples R China

[3] Chinese Peoples Liberat Army Gen Hosp, Dept Gynecol & Obstet, Beijing, Peoples R China

[4] Chinese Peoples Liberat Army Gen Hosp, Mol & Immunol Dept, Biotherapeut Dept, Beijing, Peoples R China

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

6071

引用

页数：2